Financial Performance - The company's operating revenue for Q1 2025 reached ¥252,990,448.80, representing a 126.90% increase compared to ¥111,499,399.27 in the same period last year[4] - Net profit attributable to shareholders was ¥43,400,879.01, up 147.35% from ¥17,546,549.49 year-on-year[4] - The net profit after deducting non-recurring gains and losses increased by 163.91%, amounting to ¥40,238,336.17 compared to ¥15,247,070.02 in the previous year[4] - Operating profit for Q1 2025 was ¥50,598,107.74, up 145.0% from ¥20,613,268.99 in Q1 2024[20] - Net profit for Q1 2025 was ¥43,948,209.77, representing a 149.0% increase from ¥17,588,997.57 in Q1 2024[21] - Basic and diluted earnings per share for Q1 2025 were both ¥0.19, compared to ¥0.08 in Q1 2024[21] Assets and Liabilities - The company's total assets grew by 37.85% to ¥2,158,052,712.76 from ¥1,565,502,448.06 at the end of the previous year[5] - As of March 31, 2025, total assets reached CNY 2,158,052,712.76, an increase from CNY 1,565,502,448.06 on December 31, 2024, representing a growth of approximately 37.8%[16][18] - Current assets totaled CNY 877,088,883.41, up from CNY 774,565,765.24, indicating an increase of about 13.3%[16] - The company's cash and cash equivalents decreased to CNY 325,596,757.87 from CNY 503,612,438.85, a decline of approximately 35.4%[16] - Accounts receivable rose significantly to CNY 148,431,627.89 from CNY 41,143,550.96, marking an increase of about 260.5%[16] - Inventory increased to CNY 296,715,054.09 from CNY 198,337,590.43, reflecting a growth of approximately 49.6%[16] - Total liabilities amounted to CNY 636,412,264.00, compared to CNY 147,318,544.04, showing a substantial increase of about 332.5%[18] - The company's equity attributable to shareholders reached CNY 1,384,531,474.80, up from CNY 1,341,130,595.79, a growth of approximately 3.2%[18] - Non-current assets increased to CNY 1,280,963,829.35 from CNY 790,936,682.82, representing a growth of about 62.0%[17] - The company reported a significant increase in fixed assets, which rose to CNY 1,000,080,029.07 from CNY 690,371,356.03, an increase of approximately 44.8%[17] - The total liabilities to equity ratio increased significantly, indicating a higher leverage position for the company[18] Cash Flow - The net cash flow from operating activities decreased by 61.00%, amounting to ¥15,677,326.99 compared to ¥40,195,112.30 in the previous year[4] - Cash flow from operating activities for Q1 2025 was ¥15,677,326.99, down 61.0% from ¥40,195,112.30 in Q1 2024[23] - Cash flow from investing activities for Q1 2025 showed a net outflow of ¥218,626,348.85, compared to a net outflow of ¥43,808,662.19 in Q1 2024[24] - Cash flow from financing activities for Q1 2025 resulted in a net outflow of ¥1,799,622.33, contrasting with a net inflow of ¥812,835.28 in Q1 2024[24] - The ending cash and cash equivalents balance for Q1 2025 was ¥293,749,982.57, down from ¥445,242,957.84 in Q1 2024[24] Research and Development - Research and development expenses totaled ¥11,262,656.76, a 65.09% increase from ¥6,822,009.05, accounting for 4.45% of operating revenue[5] - The company incurred research and development expenses of ¥11,262,656.76 in Q1 2025, an increase from ¥6,822,009.05 in Q1 2024[20] Revenue Drivers - The company attributed the increase in revenue and net profit to higher sales volume and the acquisition of subsidiaries[10] - Total operating costs for Q1 2025 were ¥204,362,998.62, up 117.0% from ¥94,040,763.98 in Q1 2024[20]
同益中(688722) - 2025 Q1 - 季度财报